Heat sterilized PD-fluids impair growth and inflammatory responses of cultured cell lines and human leukocytes.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Clinical Nephrology

• Publication date

  1993-06-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  PMID 8392917
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929.

  1991cited by this paper
• Leukotriene release from peripheral and peritoneal leukocytes following exposure to peritoneal dialysis solutions.

  1991cited by this paper
• Leukotriene B4 and tumor necrosis factor release from leukocytes: effect of peritoneal dialysate.

  1991cited by this paper
• Effects of hypertonic peritoneal dialysis solutions on neutrophil superoxide production.

  1990cited by this paper
• Composition of peritoneal dialysis solutions: potential hazards.

  1989cited by this paper
• Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages.

  1989cited by this paper
• The effect of dialysate on peritoneal phagocyte oxidative metabolism.

  1988cited by this paper
• Suppression of Neutrophil Superoxide Production by Conventional Peritoneal Dialysis Solution

  1988cited by this paper
• Toxicity determined in vitro by morphological alterations and neutral red absorption.

  1985cited by this paper
• Functional macrophage cell lines transformed by Abelson leukemia virus.

  1978cited by this paper

• Detections of Chemicals and Migratory Plastics in Peritoneal Dialysis Fluids

  2024cites this paper
• Does Far-Infrared Therapy Improve Peritoneal Function and Reduce Recurrent Peritonitis in Peritoneal Dialysis Patients?

  2022cites this paper
• Does Far-Infrared Therapy Improve Peritoneal Function and Reduce Peritonitis Recurrent in Peritoneal Dialysis Patients?

  2022cites this paper
• The Effect of Far-Infrared Therapy on the Peritoneal Expression of Glucose Degradation Products in Diabetic Patients on Peritoneal Dialysis

  2021cites this paper
• Low GDP Solution and Glucose-Sparing Strategies for Peritoneal Dialysis.

  2017cites this paper
• Chemistry and clinical relevance of carbohydrate degradation in drugs.

  2016cites this paper
• Peritoneal Dialysis Solutions

  2016cites this paper
• Peritoneal Dialysis Clinical Trials: A Critical Appraisal

  2015cites this paper
• Are the Mesothelial-to-Mesenchymal Transition, Sclerotic Peritonitis Syndromes, and Encapsulating Peritoneal Sclerosis Part of the Same Process?

  2013cites this paper
• Peritoneal Dialysis—Moving from Current Status to the Future

  2013cites this paper
• Rapid and reliable measurement for evaluating directly the reactivity of N-acetylcysteine with glucose degradation products in peritoneal dialysis fluids.

  2011cites this paper
• Cytotoxic Glucose Degradation Products in Fluids for Peritoneal Dialysis

  2011cites this paper
• 15 – Defensas peritoneales

  2009cites this paper
• Peritoneal damage by peritoneal dialysis solutions

  2008cites this paper
• Peritonealdialyselösungen – differenzierte Therapie und klinische Konsequenzen

  2007cites this paper
• Reducing the formation of glucose degradation products in peritoneal dialysis solutions by ultrahigh temperature ohmic heating.

  2007cites this paper
• How to Avoid Glucose Degradation Products in Peritoneal Dialysis Fluids

  2006cites this paper
• Epithelial to Mesenchymal Transition of Mesothelial Cells as a Mechanism Responsible for Peritoneal Membrane Failure in Peritoneal Dialysis Patients

  2006cites this paper
• Glucose Degradation Products and the Peritoneum — how Sweet Things Can Turn Bitter

  2006cites this paper
• Effects of New Peritoneal Dialysis Solutions on Leukocyte Recruitment in the Rat Peritoneal Membrane

  2005cites this paper
• The transport barrier in intraperitoneal therapy.

  2005cites this paper
• Impact of Glucose in Peritoneal Dialysis: Saint or Sinner?

  2005cites this paper
• The Effects of Peritoneal Dialysis Solutions on Peritoneal Host Defense

  2004cites this paper
• Formaldehyde scavenging from peritoneal dialysis solutions using reduced aminothiol compounds

  2004cites this paper
• The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane.

  2004cites this paper
• Evidence for Less Irritation to the Peritoneal Membrane in Rats Dialyzed with Solutions Low in Glucose Degradation Products

  2004cites this paper
• Temperature: The Single Most Important Factor for Degradation of Glucose Fluids during Storage

  2004cites this paper
• Now you See Them, Now you Don't

  2004cites this paper
• Long-term results with low glucose degradation product content in peritoneal dialysis fluids.

  2003cites this paper
• The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.

  2003cites this paper
• Recent Concepts in the Molecular Biology of the Peritoneal Membrane – Implications for More Biocompatible Dialysis Solutions

  2003cites this paper
• Apoptosis of mesothelial cells caused by unphysiological characteristics of peritoneal dialysis fluids.

  2003cites this paper
• Glucose degradation products (GDP) retard remesothelialization independently of D-glucose concentration.

  2003cites this paper
• In vitro biocompatibility performance of Physioneal.

  2003cites this paper
• Glucose Degradation Products in Peritoneal Dialysis: From Bench to Bedside

  2003cites this paper
• Beyond the membrane--the role of new PD solutions in enhancing global biocompatibility.

  2003cites this paper
• Glucose degradation products increase apoptosis of human mesothelial cells.

  2003cites this paper
• Biocompatibility of icodextrin.

  2002cites this paper
• How to Reduce 3-Deoxyglucosone and Acetaldehyde in Peritoneal Dialysis Fluids

  2002cites this paper
• A peritoneal dialysis solution prepared from a three-compartment bag: biological and clinical effects.

  2001cites this paper
• The un-physiology of peritoneal dialysis solution and the peritoneal membrane: from basic research to clinical nephrology.

  2001cites this paper
• Prolonged preservation of rat peritoneal mesothelial cells (RPMC) and rat peritoneal fibroblasts (RPFB) with neutral pH peritoneal dialysis solution depleted of glucose degradation products (GDPs)

  2001cites this paper
• Protection by glutathione of neutrophils against the toxic effects of peritoneal dialysis fluid.

  2001cites this paper
• Glucose Degradation Products and Peritoneal Membrane Function

  2001cites this paper
• Very High Daily Intraperitoneal Doses of Carbonyl Compounds Affect the Morphology, but Not the Exchange Characteristics, of Rat Peritoneum

  2001cites this paper
• Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products.

  2001cites this paper
• Uremic Toxicity: Present State of the Art

  2001cites this paper
• Biologic Significance of Reduced Levels of Glucose Degradation Products

  2001cites this paper
• Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells.

  2001cites this paper
• Innovative approaches to the preservation of the peritoneal membrane: from bench to bedside.

  2001cites this paper
• Evolution of Continuous Flow Peritoneal Dialysis and the Current State of the Art

  2001cites this paper
• Glucose Degradation Products in Peritoneal Dialysis Fluids May Have Both Local and Systemic Effects: A Study of Residual Fluid and Mesothelial Cells

  2001cites this paper
• Reduced 1,2-Dicarbonyl Compounds in Bicarbonate/Lactate-Buffered Peritoneal Dialysis (PD) Fluids and PD Fluids Based on Glucose Polymers or Amino Acids

  2000cites this paper
• Biological Significance of Reducing Glucose Degradation Products in Peritoneal Dialysis Fluids

  2000cites this paper
• Chemical peritonitis associated with high dialysate acetaldehyde concentrations.

  2000cites this paper
• Biocompatibility of New Peritoneal Dialysis Solutions

  2000cites this paper
• A New Lactate-Based, Plasticizer-Free, Neutral Peritoneal Dialysis Fluid Provided in a Two-Compartment System: Effect on Peripheral Leukocyte Function

  2000cites this paper
• Peritoneal Sclerosis: One or Two Nosological Entities?

  2000cites this paper
• Glucose Degradation Products: Relationship with Cell Damage

  2000cites this paper
• Effects of Conventional and New Peritoneal Dialysis Solutions on Human Peritoneal Mesothelial Cell Viability and Proliferation

  2000cites this paper
• Glucose Degradation Products and the Peritoneal Mesothelium

  2000cites this paper
• Biocompatibility of New Peritoneal Dialysis Solutions: Clinical Experience

  2000cites this paper
• Effect of glucose degradation products on human peritoneal mesothelial cell function.

  2000cites this paper
• Peritoneal inflammation and long-term changes in peritoneal structure and function

  2000cites this paper
• Kinetics and Dose Response of the Effects of Heated Glucose Peritoneal Dialysis Fluids on the Respiratory Burst of Rat Peritoneal Leukocytes

  2000cites this paper
• Long-term peritoneal membrane changes.

  2000cites this paper
• The Effect of Hemodialysis during Break-In Period on Residual Renal Function in CAPD Patients

  2000cites this paper
• Biocompatibility and New Fluids

  1999cites this paper
• Effect of pH and glucose on cultured human peritoneal mesothelial cells.

  1999cites this paper
• Induction of 1,2-Dicarbonyl Compounds, Intermediates in the Formation of Advanced Glycation End-Products, during Heat-Sterilization of Glucose-Based Peritoneal Dialysis Fluids

  1999cites this paper
• Effect of icodextrin peritoneal dialysis solution on cell proliferation in vitro.

  1999cites this paper
• Peritoneal sclerosis.

  1999cites this paper
• The Impact of Sterilization Methods on the Quality of Peritoneal Dialysis Solutions

  1999cites this paper
• Low concentrations of glucose degradation products in peritoneal dialysis fluids and their impact on biocompatibility parameters: prospective cross-over study with a three-compartment bag.

  1999cites this paper
• Effect of glucose concentration, osmolality, and sterilization process of peritoneal dialysis fluids on cytokine production by peripheral blood mononuclear cells and polymorphonuclear cell functions in vitro.

  1998cites this paper
• Effects of Acidity, Glucose Degradation Products, and Dialysis Fluid Buffer Choice on Peritoneal Solute and Fluid Transport in Rats

  1998cites this paper
• N-Acetylglucosamine Changes Permeability of Peritoneum during Chronic Peritoneal Dialysis in Rats

  1998cites this paper
• Advances in Peritoneal Dialysis: Towards Improved Efficacy and Safety

  1998cites this paper
• Comparison of in vitro AGE formation between standard PD fluid and a novel bicarbonate/lactate formulation.

  1998cites this paper
• Formaldehyde in Heat Sterilized Peritoneal Dialysis Solutions: Scavenging System for Its Removal

  1998cites this paper
• Impact of terminal heat sterilization on the quality of peritoneal dialysis solutions.

  1997cites this paper
• In Vivo Model to Study the Biocompatibility of Peritoneal Dialysis Solutions

  1997cites this paper
• In vitro biocompatibility of bicarbonate-based peritoneal dialysis solutions.

  1997cites this paper
• Reduced Glucose Degradation Products in Bicarbonate/Lactate-Buffered Peritoneal Dialysis Solutions Produced in Two-Chambered Bags

  1997influential citation
• Inhibition of p75 Tumor Necrosis Factor Receptor by Antisense Oligonucleotides Increases Hypoxic Injury and β-Amyloid Toxicity in Human Neuronal Cell Line*

  1997cites this paper
• Peritoneal Dialysis Solution Biocompatibility: Inhibitory Mechanisms and Recent Studies with Bicarbonate-Buffered Solutions

  1997cites this paper
• Effect of two-chambered bicarbonate lactate-buffered peritoneal dialysis fluids on peripheral blood mononuclear cell and polymorphonuclear cell function in vitro.

  1997cites this paper
• Glucose Degradation and Cytotoxicity in Pd Fluids

  1996cites this paper
• In Vitro Studies to Assess Biocompatibility of Peritoneal Dialysis Solutions: Strengths and Limitations

  1996cites this paper
• Daily short exposure of cultured mesothelial cells to lactated, high-glucose, low-pH peritoneal dialysis fluid induces a low-profile regenerative steady state

  1996cites this paper
• Effect of Different Buffers on the Biocompatibility of Capd Solutions

  1996cites this paper
• Biocompatibility of peritoneal dialysis solutions and host defense.

  1996cites this paper
• Heat-Sterllized Pd Fluid Blocks Leukocyte Adhesion and Increases Flow Velocity in Rat Peritoneal Venules

  1996cites this paper
• Altered cellular biosynthesis in human peritoneal mesothelial cells exposed to dialysis solutions.

  1996cites this paper
• Daily short exposure of cultured mesothelial cells to lactated, high-glucose, low-pH peritoneal dialysis fluid induces a low-profile regenerative steady state.

  1996cites this paper
• Cytotoxicity of peritoneal dialysis fluid - is it related to glucose breakdown products?

  1996cites this paper
• Biocompatibility of peritoneal dialysis solutions.

  1996cites this paper
• Effect of peritoneal dialysis on cytokine production by peritoneal cells.

  1996cites this paper
• Are Solutions Presently Used Bioincompatible?

  1995cites this paper
• Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis.

  1995cites this paper